Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nausea × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 103 Neoplasms, Plasma Cell 31 Neoplasms 12 Brain Neoplasms 12 Recurrence 11 Central Nervous System Neoplasms 11 Glioblastoma 10 Carcinoma, Hepatocellular 10 Melanoma 9 Prostatic Neoplasms 8 Leukemia 8 Gliosarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 7 Waldenstrom Macroglobulinemia 6 Lung Neoplasms 6 Glioma 6 Sarcoma 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Immunoglobulin Light-chain Amyloidosis 5 Colorectal Neoplasms 5 Myelodysplastic Syndromes 4 Lymphoma 4 Colonic Neoplasms 4 Astrocytoma 4 Rectal Neoplasms 3 Oligodendroglioma 3 Neuroblastoma 3

Interventions

Dexamethasone 30 Aprepitant 28 Ondansetron 22 Palonosetron 21 Granisetron 15 Olanzapine 13 Calcium Dobesilate 12 dexamethasone acetate 7 Therapeutics 7 Cyclophosphamide 7 casopitant 6 Doxorubicin 6 netupitant 4 fosaprepitant 4 dolasetron 4 dexamethasone 21-phosphate 4 Vincristine 4 Radiotherapy 4 Metoclopramide 4 Acupressure 4 Tropisetron 3 Prochlorperazine 3 Electroacupuncture 3 Dronabinol 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 auricularum 2 Tablets 2 Sugars 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡